a 66

A66 is a specific and effective p110α inhibitor(IC50=32 nM).

LL-37, Human acetate is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity.

Compound FL0153, with CAS No. 278788-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0153 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0181, with CAS No. 158063-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0181 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12177, with CAS No. 2923-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12177 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13401, with CAS No. 26475-66-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13401 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13714, with CAS No. 14268-66-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13714 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13871, with CAS No. 673-66-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13871 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14116, with CAS No. 51-66-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14116 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

2-(3-HYDROXYPROPYL)BENZIMIDAZOLE, with CAS No. 2403-66-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-(3-HYDROXYPROPYL)BENZIMIDAZOLE provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0282, with CAS No. 579-66-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0282 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0329, with CAS No. 66521-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0329 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0357, with CAS No. 7506-66-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0357 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Lithocholic acid (3α-Hydroxy-5β-cholanic acid) is a toxic secondary bile acid, They were FXR antagonists (IC50=0.7, 1.4 μM), EphA2 antagonists (IC50=48, 66 μM) and EphB4 antagonists (IC50=141 μM). Lithocholic acid can promote intrahepatic cholestasis and promote tumorigenesis. Lithocholic acid is a cleanser that dissolves fat for absorption and is itself absorbed.

1,2-Diphenoxyethane is composed of two phenoxy groups connected by ethane and is widely used in biochemical experiments and drug synthesis research.

Compound EN300-21005, with CAS No. 5785-66-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound EN300-21005 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

4-Chlorophenylacetic acid is a useful organic compound for research related to life sciences. The catalog number is T65823 and the CAS number is 1878-66-6.

Compound Fr12999, with CAS No. 852180-66-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12999 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13107, with CAS No. 550347-66-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13107 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13291, with CAS No. 219865-66-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13291 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13321, with CAS No. 65032-66-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13321 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13377, with CAS No. 906352-66-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13377 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13542, with CAS No. 660820-66-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13542 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13770, with CAS No. 505-66-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13770 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.